Cointime

Inserm Transfert Initiative

investment firm

About

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech

Highlights

Investments
21
Lead Investments
1
Exits
5
Employee Profiles
5

Details

Industries
Biotechnology,Finance,Life Science
Operating Status
Active
Investor Type
Angel Group

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Investments

Number of Investments
Number of Lead Investments
21
1
Inserm Transfert Initiative has made 21 investments. Their most recent investment was on Oct 19, 2020, when VectivBio raised $110M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 19, 2020 VectivBio
Series Unknown $110M Biotechnology —
Jan 8, 2020 VectivBio
Series A $35M Biotechnology —
Jan 8, 2020 Eyevensys
Series B $30M Biotechnology —
Dec 13, 2019 Aelis Farma
Series Unknown €11M Biotechnology —
Aug 9, 2018 Therachon
Series B $60M Biotechnology —
Show More

Employee Profiles

Number of Employee Profiles
5
Inserm Transfert Initiative has 5 current employee profiles, including Executive Chahra Louafi
Chahra Louafi
Executive
Jean-Jacques Garaud
Board member
François Thomas
Board member
Hervé Brailly
Board member

Exits

Inserm Transfert Initiative has had 5 exits. Inserm Transfert Initiative most notable exits include Aelis Farma ,   VectivBio

Date Company Name Exit Type Industry
Feb 16, 2022 Aelis Farma IPO Biotechnology Detail
Apr 8, 2021 VectivBio IPO Biotechnology Detail
May 8, 2019 Therachon M&A Biotechnology Detail
Apr 30, 2015 Sensorion IPO Biopharma Detail
Jan 1, 2006 Pharma Omnium M&A Health Care Detail
Cointime
Content
Company